Prohost Biotech - Exclusive Biotech Research - A Comprehensive Resource for Biotech News

Encouraging News About the COVID-19 Outbreak. See Also: Important News from Gilead

April 8, 2020 0

COVID-19 at Its Peak? The number of deaths from the COVID-19 outbreak in NYC are expected …

The Time Has Come for Us To Present Fate Therapeutics

April 3, 2020 0

Presenting Fate Therapeutics Today we are presenting Fate Therapeutics (FATE); a clinical-stage company developing programmed cellular immunotherapies …

We Introduce UroGen Pharma and Discuss Its Pipeline of Products

April 2, 2020 0

Presenting UroGen Pharma UroGen Pharma (URGN) focuses on cancers and urologic diseases. It announced its fourth quarter …

Two Companies Coronavirus Will Fail To Disrupt

March 31, 2020 0

Vertex and Regeneron Will Survive the Coronavirus Market Vertex We picked Vertex (VRTX) on March 18, …

Why We Are Still Optimistic. See Also: Inovio’s Good News

March 27, 2020 0

COVID-19 and the Nation's Hospitals Disagreeable news with regard to the nation's hospitals is their unpreparedness …

Good News for Exelixis and for Japanese Renal Cell Carcinoma Patients

March 25, 2020 0

Exelixis, Takeda and Japanese RCC Patients Today we learned from Exelixis (EXEL) that Takeda Pharmaceutical Company …

Stars Before the Coronavirus Outbreak and Those Firms Treating COVID-19

March 24, 2020 0

The Week in Review #49 The Stars from the Weeks Preceding the Novel Coronavirus Outbreak Forty …

Its All About Coronavirus

March 19, 2020 0

Coronavirus: The Possible Treatments While Moderna’s (MRNA) vaccine is being tested and its stock price continued …

A Market in Chaos. Moderna’s Human Trial Began Today

March 16, 2020 0

A Market in Chaos The Market is in chaos. When this happens the market needs to …

The Market Rebounding That Left Important Biotechnology Firms Behind

March 13, 2020 0

COVID-19, The Market Rebounding and the Biotech Firms That Did and Didn't Rally The Market Rebounding …

Market Frustration, Volatility and Chaos

March 12, 2020 0

Stock Market Fluctuations and Volatility Only history can remind us that what’s going on recently with …

The Small Stock That Refused to Kneel in Today’s Market

March 9, 2020 0

Compugen Soaring in an Extremely Down Market The stocks' prices tumbled today except for very few …

How the Stock Prices of Firms Developing Treatments or Vaccines Have Started the Day

March 6, 2020 0

NanoViricides and COVID-19 NanoViricides (NNVC), a development-stage nano-biopharmaceutical company with a proprietary and patented drug development …

Fighting COVID-19. See Also: Stocks Gains Following the Market’s Rebounding

March 5, 2020 0

Treating and Preventing COVID-19 Treating COVID-19, Gilead Sciences With regard to treating patients with COVID-19 we …

Optimism: The Market is Rebounding and Biotech Firms Inspiring News

March 2, 2020 0

The Market Soared Being optimistic about the greatness of American scientific capability does not mean underestimating …

Gilead Sciences To Acquire Forty Seven at $95.50 a Share in Cash

March 2, 2020 0

Gilead Sciences to Acquire Forty Seven Gilead Sciences (GILD) and Forty Seven (FTSV) announced today that the companies …

More About Moderna, Gilead and Forty Seven

February 28, 2020 0

Moderna Therapeutics Among all the firms announcing their interest in working towards designing and producing a …

COVID-19 and the Stock Market

February 27, 2020 0

COVID-19 and the Stock Market The coronavirus that causes COVID-19 is the topic that swallowed all other …

Regeneron and Moderna Are Both Outperforming Today

February 25, 2020 0

Regeneron, Moderna, and COVID-19 The spread of COVID-19, minute creatures that seem to be trying to …

Biotech Stocks Expected to Outperform in Today’s Tumbling Market

February 24, 2020 0

Gilead and Moderna Stocks Will Outperform Today As stated in Prohost Letter #439 Gilead (GILD) investigational …

Exclusive Market Insight

& Scientific analysis

Latest Articlesddd

Encouraging News About the COVID-19 Outbreak. See Also: Important News from Gilead

The Time Has Come for Us To Present Fate Therapeutics

We Introduce UroGen Pharma and Discuss Its Pipeline of Products

Two Companies Coronavirus Will Fail To Disrupt

Why We Are Still Optimistic. See Also: Inovio’s Good News

Good News for Exelixis and for Japanese Renal Cell Carcinoma Patients

Stars Before the Coronavirus Outbreak and Those Firms Treating COVID-19

Its All About Coronavirus

A Market in Chaos. Moderna’s Human Trial Began Today

The Market Rebounding That Left Important Biotechnology Firms Behind

Market Frustration, Volatility and Chaos

The Small Stock That Refused to Kneel in Today’s Market

How the Stock Prices of Firms Developing Treatments or Vaccines Have Started the Day

Fighting COVID-19. See Also: Stocks Gains Following the Market’s Rebounding

Optimism: The Market is Rebounding and Biotech Firms Inspiring News

Gilead Sciences To Acquire Forty Seven at $95.50 a Share in Cash

More About Moderna, Gilead and Forty Seven

COVID-19 and the Stock Market

Regeneron and Moderna Are Both Outperforming Today

Biotech Stocks Expected to Outperform in Today’s Tumbling Market